Acknowledgements and funding
MR309 was developed by Esteve (Barcelona, Spain). Mundipharma Research Ltd. funded this research.
Medical writing support was provided by Siân Marshall, of SIANTIFIX Ltd., Cambridge, UK, funded by Mundipharma Research Limited.